GlaxoSmithKline plc (GSK) Up 0.83% in Premarket Trading

GlaxoSmithKline plc (GSK) has gained Wednesday morning, with the stock adding 0.83% in pre-market trading to 42.73. GSK's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Drug Manufacturers - General industry, which ranks 107 out of 146 industries, the stock ranks higher than 97% of stocks. GlaxoSmithKline plc has fallen 2.55% over the past month, closing at $43.18 on November 10. During this period of time, the stock fell as low as $41.02 and as high as $43.54. GSK has an average analyst recommendation of Buy. The company has an average price target of $47.75.

GSK has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on GSK!

See Full GSK Report

GlaxoSmithKline plc has a Long-Term Technical rank of 78. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 22% of the market scoring higher. In the Drug Manufacturers - General industry which is number 110 by this metric, GSK ranks better than 90% of stocks.

Important Dates for Investors in GSK:

-GlaxoSmithKline plc is set to release earnings on 1/25/2022. During their last earnings release the company posted EPS of $2.00. -We do not have a set dividend date for GlaxoSmithKline plc at this time. Click Here To Get The Full Report on GlaxoSmithKline plc (GSK)